| 臺大學術典藏 |
2022-09-09T03:32:41Z |
Conditional Expression In The Zebrafish Heart With Tet-On Regulatory System
|
Hsieh, FJ; TZUU-SHUH JOU |
| 臺大學術典藏 |
2022-09-09T04:21:16Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:18Z |
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma
|
Wang S.-Y.; Su T.-H.; Chen B.-B.; Liu C.-J.; Liu C.-H.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:18Z |
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
|
Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:19Z |
Paradigm shift in the treatment options of hepatocellular carcinoma
|
Su T.-H.; Hsu S.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:20Z |
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities
|
Hsu Y.-C.; Tseng C.-H.; Su T.-H.; JIA-HORNG KAO; Nguyen M.H. |
| 臺大學術典藏 |
2022-09-09T04:21:20Z |
Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosis
|
Liu C.-H.; Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:21Z |
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients with Indeterminate Phase
|
Tseng T.-C.; Hosaka T.; Liu C.-J.; Suzuki F.; Hong C.-M.; Kumada H.; Yang W.-T.; Hsu C.-Y.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen H.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:21Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:22Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang S.-C.; Cheng P.-N.; Liu C.-H.; Yang H.-C.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO; Liu C.-J. |
| 臺大學術典藏 |
2022-09-09T04:21:22Z |
Strategies for hepatitis C virus treatment failure
|
Huang S.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:22Z |
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
|
Lim Y.-S.; Seto W.-K.; Kurosaki M.; Fung S.; JIA-HORNG KAO; Hou J.; Gordon S.C.; Flaherty J.F.; Yee L.J.; Zhao Y.; Agarwal K.; Lampertico P. |
| 臺大學術典藏 |
2022-09-09T04:21:23Z |
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
|
Lazarus J.V.; Mark H.E.; Villota-Rivas M.; Palayew A.; Carrieri P.; Colombo M.; Ekstedt M.; Esmat G.; George J.; Marchesini G.; Novak K.; Ocama P.; Ratziu V.; Razavi H.; Romero-G?mez M.; Silva M.; Spearman C.W.; Tacke F.; Tsochatzis E.A.; Yilmaz Y.; Younossi Z.M.; Wong V.W.-S.; Zelber-Sagi S.; Cortez-Pinto H.; Anstee Q.M.; Rouabhia S.; Ghazinyan H.; Iskandar N.J.; Trauner M.; Aghayeva G.; Carter F.; Sridharan K.; Al Mahtab M.; Francque S.; Kodjoh N.; Camacho R.M.; Anderson M.; Marques Souza de Oliveira C.P.; Mateva L.; Serme A.K.; Soares Martins A.A.; Swain M.G.; Komas N.P.; Zheng M.-H.; Jaramillo P.L.; Murillo O.A.; Mikolasevic I.; Vounou E.; Br?ha R.; Nlombi C.M.; Thiele M.; Perez M.; Su?rez M J.J.; Waked I.; Salupere R.; Desalegn H.; Yki-J?rvinen H.; Tsertsvadze T.; Sharvadze L.; Butsashvili M.; Awuku Y.A.; Papatheodoridis G.; Hunyady B.; Bjornsson E.S.; Duseja A.; Lesmana C.R.A.; Malekzadeh R.; Norris S.; Koike K.; Nersesov A.V.; Ochwoto M.; Jamal M.; Saparbu T.; Tolmane I.; Sayegh R.; Sheriff D.S.; Valantinas J.; Weber J.; Shawa I.T.; Tan S.-S.; Mart?nez V?zquez S.E.; Baatarkhuu O.; Lkhagvaa U.; Jadamba T.; Mohammed T.; Sudhamshu K.C.; Coppell K.; Onyekwere C.; Nikolova D.; Vesterhus M.; Al-Naamani K.; Hamid S.; M?ndez J.P.; Cabrera Cabrejos M.C.; Flisiak R.; Torres E.A.; Taheri S.; Sung K.-C.; Adela T.; Gheorghe L.; Sanai F.M.; Milovanovic T.; Bee Goh G.B.; Rac M.; Dassanayake A.; Osama S.B.; Elsanousi M.; Dufour J.-F.; JIA-HORNG KAO; Saidi D.; Treeprasertsuk S.; Koek G.; Labidi A.; Skrypnyk I.; AlKhatry M.S.; Sadirova S.; Bakieva S.; Sinkala E.; NAFLD policy review collaborators |
| 臺大學術典藏 |
2022-09-09T04:21:24Z |
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine
|
Park J.; Le A.K.; Tseng T.-C.; Yeh M.-L.; Jun D.W.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung K.S.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H. |
| 臺大學術典藏 |
2022-09-09T04:21:24Z |
Letter to the editor: New kid in the playground: HBcrAg and risk of HCC
|
Wu J.-W.; Tseng T.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
|
Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study
|
Papatheodoridi M.; Su T.-H.; Hadziyannis E.; Liao C.-H.; Orfanidou Α.; Yang H.-C.; Zachou K.; Liu C.-J.; Kourikou A.; Gatselis N.; Manolakopoulos S.; Dalekos G.; JIA-HORNG KAO; Hadziyannis S.; Papatheodoridis G.V. |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
|
You H.; Ma X.; Efe C.; Wang G.; Jeong S.-H.; Abe K.; Duan W.; Chen S.; Kong Y.; Zhang D.; Wei L.; Wang F.-S.; Lin H.-C.; Yang J.M.; Tanwandee T.; Gani R.A.; Payawal D.A.; Sharma B.C.; Hou J.; Yokosuka O.; Dokmeci A.K.; Crawford D.; JIA-HORNG KAO; Piratvisuth T.; Suh D.J.; Lesmana L.A.; Sollano J.; Lau G.; Sarin S.K.; Omata M.; Tanaka A.; Jia J. |
| 臺大學術典藏 |
2022-09-09T04:21:26Z |
Response to “Iodized Oil CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Within Milan Criteria”
|
Wu C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:26Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:28Z |
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
|
Liu C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:28Z |
Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B
|
Huang S.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:29Z |
Looking Into the Crystal Ball: A Novel Biomarker for Outcomes of Patients With Chronic Hepatitis B Virus Infection
|
Tseng T.-C.; Wu J.-W.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:29Z |
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
|
Lin C.-L.; Tai C.-M.; Huang J.-F.; Liu C.-J.; Chen H.-F.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Wang C.-C.; Weng S.-H.; Tseng T.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:29Z |
Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function
|
Li Y.-T.; Liu C.-J.; JIA-HORNG KAO; Lin L.-F.; Tu H.-C.; Wang C.-C.; Huang P.-H.; Cheng H.-R.; Chen P.-J.; Chen D.-S.; Wu H.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:30Z |
Letter: hepatic steatosis and fibrosis in chronic hepatitis B—the chicken-and-egg conundrum
|
Huang S.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:30Z |
Advancing the global public health agenda for NAFLD: a consensus statement
|
Lazarus J.V.; Mark H.E.; Anstee Q.M.; Arab J.P.; Batterham R.L.; Castera L.; Cortez-Pinto H.; Crespo J.; Cusi K.; Dirac M.A.; Francque S.; George J.; Hagstr?m H.; Huang T.T.-K.; Ismail M.H.; Kautz A.; Sarin S.K.; Loomba R.; Miller V.; Newsome P.N.; Ninburg M.; Ocama P.; Ratziu V.; Rinella M.; Romero D.; Romero-G?mez M.; Schattenberg J.M.; Tsochatzis E.A.; Valenti L.; Wong V.W.-S.; Yilmaz Y.; Younossi Z.M.; Zelber-Sagi S.; ?berg F.; Adams L.; Khatry M.S.A.; Naamani K.A.; Murillo O.A.; Allen A.M.; Alnaser F.; Alqahtani S.A.; Alswat K.; Alvaro D.; Andrade R.J.; Arrese M.; Awuku Y.A.; Ayesha M.; Baatarkhuu O.; Bakieva S.; Basu R.; Bataller R.; Bedri S.; Bosi E.; Bourliere M.; Bruha R.; Bugianesi E.; Burra P.; Buti M.; Byrne C.D.; Calleja J.L.; Carrieri P.; Carter F.; Fernandez M.I.C.; Castillo-Lopez G.; Castro-Narro G.E.; Chan H.L.Y.; Chan W.-K.; Chang Y.; Colombo M.; Coppell K.J.; Corey K.; Craxi A.; Cryer D.; Dassanayake A.; Martins A.A.S.; de Ledinghen V.; DelPrato S.; Demaio A.; Desalegn H.; Dillon J.; Duseja A.; Dorairaj P.; Ekstedt M.; El Kassas M.; Elsanousi O.M.; Esmat G.; Fan J.-G.; Farpour-Lambert N.; Flisiak R.; Fouad Y.; Fuchs M.; Gani R.A.; Gerber L.; Ghazinyan H.; Gheorghe L.; Goh G.B.-B.; Gr?nb?k H.; Gulnara A.; Hamid S.; Hebditch V.; Hickman I.J.; Hocking S.L.; Hunyady B.; Idilman R.; Isakov V.A.; Jamal M.H.; Jepsen P.; Iskandar N.J.; Song M.J.; Sudhamshu K.C.; Kakizaki S.; Kalamitsis G.; Kanwal F.; JIA-HORNG KAO; Kaplan L.; Kawaguchi T.; Khader Y.; Kim S.U.; Kodjoh N.; Koek G.; Koike K.; Komas N.P.; Korenjak M.; Kugelmas M.; Labidi A.; Lange N.F.; Lavine J.E.; Lazo M.; Lee N.; Lesmana C.R.A.; Liu C.-J.; Long M.T.; Lopez-Jaramillo P.; Malekzadeh R.; Mahtab M.A.; Marchesini G.; Marinho R.; V?zquez S.E.M.; Mateva L.; Nlombi C.M.; Melin P.; Mikolasevic I.; Milovanovic T.; Musso C.; Nakajima A.; Nava E.; Nersesov A.V.; Nikolova D.; Norris S.; Novak K.; Oben J.; Ong J.P.; Onyekwere C.; Papatheodoridis G.; Paruk I.; Patel K.; Macedo M.P.; Penha-Gon?alves C.; Figueroa M.P.; Hofmann W.P.; Petta S.; de Oliveira C.P.M.S.; Puri P.; Pan C.Q.; Rac M.; Ralston J.; Ramji A.; Razavi H.; Alvares-da-Silva M.R.; Roberts S.; Roden M.; Rose T.; Rouabhia S.; Rovere-Querini P.; Rowe I.A.; Sadirova S.; Salupere R.; Saparbu T.; Sayegh R.; Sebastiani G.; Seki Y.; Selmo J.; Serme A.K.; Shaw J.E.; Shenoy T.; Sheron N.; Shibolet O.; Silva M.; Skrypnyk I.; Socha P.; Soriano J.; Spearman C.W.; Sridharan K.; Su?rez J.J.; Sheriff D.S.; Sung K.-C.; Swain M.; Tacke F.; Taheri S.; Tan S.-S.; Tapper E.B.; Yki-J?rvinen H.; Thiele M.; Shawa I.T.; Tolmane I.; Torres E.A.; Trauner M.; Treeprasertsuk S.; Turcanu A.; Valantinas J.; Vesterhus M.; Waked I.; Wild S.H.; Willemse J.; Wong R.J.; Xanthakos S.; Young D.Y.; Yu M.-L.; Zheng K.I.; Zeybel M.; Zheng M.-H.; the NAFLD Consensus Consortium |
| 臺大學術典藏 |
2022-09-09T04:21:31Z |
Management of non-alcoholic fatty liver disease in patients with sarcopenia
|
Hsu C.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:31Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; Liu C.-J.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; JIA-HORNG KAO; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:32Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:32Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:33Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:33Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
Hong C.-M.; Lin Y.-Y.; Liu C.-J.; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; JIA-HORNG KAO; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J. |
| 臺大學術典藏 |
2022-09-09T04:21:34Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:34Z |
Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus
|
Liu C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:34Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:35Z |
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
|
Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
| 臺大學術典藏 |
2022-09-09T04:21:35Z |
Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan
|
Lee W.-C.; Chen T.-K.; Han H.-F.; Lin Y.-C.; Hwang Y.-M.; JIA-HORNG KAO; Chen P.-J.; Liu C.-J. |
| 臺大學術典藏 |
2022-09-09T04:21:36Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:36Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:36Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators |
| 臺大學術典藏 |
2022-09-09T04:21:37Z |
Three heads are better than two: Hepatitis b core-related antigen as a new predictor of hepatitis b virus-related hepatocellular carcinoma
|
Wu J.-W.; JIA-HORNG KAO; Tseng T.-C. |
| 臺大學術典藏 |
2022-09-09T04:21:37Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:38Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:38Z |
What we have learned from COVID-19 pandemic?
|
Chen H.-H.; JIA-HORNG KAO; Chen J.-S.; Ni Y.-H. |
| 臺大學術典藏 |
2022-09-09T04:21:38Z |
Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan
|
Liao S.-H.; Chen C.-L.; Hsu C.-Y.; Chien K.-L.; JIA-HORNG KAO; Chen P.-J.; Chen T.H.-H.; Chen C.-H. |
| 臺大學術典藏 |
2022-09-09T04:21:39Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:39Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
